Artificial Intelligence, Neuroscience, Microscopy, Deep Learning.
protocols are beginning to impact drug discovery operations. Companies such as Recursion Pharmaceuticals are using deep learning in morphological analysis (known as image-based profiling) to identify biological features and variables associated with drug response and disease-related conditions. In